Developing new vaccines to protect against influenza and COVID-19
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center
['FUNDING_OTHER'] · DUKE UNIVERSITY · NIH-11042030
This study is working on new vaccines to help protect you from different types of flu and COVID-19, and it will test how well these vaccines work and how safe they are for people like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUKE UNIVERSITY (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-11042030 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and testing innovative vaccines aimed at providing strong and lasting immunity against various strains of influenza and the COVID-19 virus. The approach includes detailed immunologic analyses to guide vaccine design, as well as laboratory testing to evaluate how effective these vaccines are in generating an immune response. Clinical trials will also be conducted to assess the safety and efficacy of these new vaccine candidates in human participants.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who are at higher risk for influenza and COVID-19, such as the elderly, those with underlying health conditions, or healthcare workers.
Not a fit: Patients who are not at risk for influenza or COVID-19, or those who have already received effective vaccines, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that provide better protection against influenza and COVID-19.
How similar studies have performed: Previous research has shown success in developing effective vaccines for influenza and COVID-19, indicating that innovative approaches in this area can yield positive results.
Where this research is happening
DURHAM, UNITED STATES
- DUKE UNIVERSITY — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MOODY, TONY — DUKE UNIVERSITY
- Study coordinator: MOODY, TONY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.